CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
February 7, 2024 6:30 AM ESTWOONSOCKET, R.I., Feb. 7, 2024 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2023.
FOURTH QUARTER HIGHLIGHTSÂ
Total revenues increased to $93.8 billion, up 11.9% compared to prior yearGAAP diluted EPS of $1.58 and Adjusted EPS of $2.12KEY FINANCIAL DATA
... More



